Veracyte traded at $22.74 this Friday June 24th, increasing $0.92 or 4.22 percent since the previous trading session. Looking back, over the last four weeks, Veracyte gained 32.83 percent. Over the last 12 months, its price fell by 45.86 percent. Looking ahead, we forecast Veracyte to be priced at 22.13 by the end of this quarter and at 20.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
22.74
Daily Change
4.22%
Yearly
-45.86%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 121.29 2.69 2.27% -17.65%
Agenus 1.90 -0.08 -4.04% -64.62%
Anika Therapeutics 22.53 -0.97 -4.13% -50.06%
Arrowhead Research 34.46 0.20 0.58% -61.85%
Biocept 0.90 -0.06 -6.40% -79.02%
Bruker 64.18 -0.68 -1.05% -13.90%
Exact Sciences 45.15 2.91 6.89% -64.88%
Heron Therapeutics 3.40 0.04 1.19% -79.54%
Illumina 193.93 0.38 0.20% -59.14%
Immunogen 4.31 -0.06 -1.37% -38.07%
Karyopharm Therapeutics 5.17 0.04 0.78% -52.96%
Ligand Pharmaceuticals 89.30 1.49 1.70% -35.93%
Laboratory Of America 242.56 2.94 1.23% -9.24%
Myriad Genetics 18.95 0.05 0.26% -41.89%
Rigel Pharmaceuticals 1.02 -0.10 -8.93% -77.53%
Roche Holding 320.75 1.95 0.61% -7.84%
Sangamo BioSciences 4.31 -0.06 -1.37% -64.14%
Sonic Healthcare 33.07 -0.24 -0.72% -11.27%
Siemens 104.24 1.62 1.58% -22.32%
Thermo Fisher Scientific 544.81 4.21 0.78% 10.54%
Veracyte 22.74 0.92 4.22% -45.86%
Waters 328.58 7.14 2.22% -2.72%
Intrexon 1.40 0 0% -79.47%

Indexes Price Day Year
USND 11608 375.43 3.34% -19.17%
US2000 1766 54.06 3.16% -24.36%

Veracyte
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.